CurrentEndo
Get Weekly

CurrentEndo coverage · page 4 of 55

Diabetes, Obesity and Metabolism

Briefs 121–160 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

  1. Diabetes Obes Metab

    Proteomic Pathways Linking Type 2 Diabetes Genetic Clusters to Cardiovascular Diseases: A Network Mendelian Randomisation Study

    Research articleT2D & other

  2. Diabetes Obes Metab

    Priorities, Expectations, Perceptions of Time in Tight Range and Support Needs Relating to Closed‐Loop Therapy Among Adults With Type 1 Diabetes: The SELECT HCL Study

    Cross-sectional studyTechnology

  3. Diabetes Obes Metab

    Trends in Cost of Care With Tirzepatide in Adults Aged Over 55 Years With Obesity or Overweight Without Diabetes: A Matched Cohort Analysis

    Cohort studyObesity

  4. Diabetes Obes Metab

    Glucose Challenge Test Values Within the Normal Range and Long‐Term Risk of Type 2 Diabetes by Pre‐Pregnancy BMI : A Retrospective Cohort Study

    Cohort studyDiabetes in pregnancy

  5. Diabetes Obes Metab

    Ten‐Year Cost‐Effectiveness of the Risk Assessment and Management Programme—Diabetes Mellitus ( RAMP ‐ DM ) Relative to Usual Care in Hong Kong Public Primary Care: A Population‐Based Cohort Study

    Cohort studyT2D & other

  6. Diabetes Obes Metab

    Variation in Treatment Patterns of Type 2 Diabetes in Older Patients

    Cohort studyT2D & other

  7. Diabetes Obes Metab

    Artificial Intelligence Analysis of Standard 12‐Lead Electrocardiograms for Screening of Symptomatic Diabetic Peripheral Neuropathy

    Diagnostic or prognostic studyComplications

  8. Diabetes Obes Metab

    Efficacy and Safety of SGLT2 Inhibitors in Patients With Genetic Lipodystrophy: A Real‐Life Experience From a National Reference Network

    Cohort studyObesity

  9. Diabetes Obes Metab

    A Comprehensive Body Shape Evaluation System With Population Reference Ranges for Improved Disease Identification: Evidence From the China National Health Survey

    Cross-sectional studyObesity

  10. Diabetes Obes Metab

    Linking Metabolic Subgroups and Adverse Pregnancy Outcomes in GDM : A Complementary Analytic Approach of Logistic Regressions and Machine Learning

    Cohort studyDiabetes in pregnancy

  11. Diabetes Obes Metab

    Omnipod 5 Delivers Superior Economic Value Compared to Multiple Daily Injections: A Cost‐Effectiveness Analysis in Adults With T1D From a Payer Perspective in Sweden

    Research articleTechnology

  12. Diabetes Obes Metab

    EASO 's New Obesity Framework and Incident Type 2 Diabetes: A Prospective Cohort Study

    Cohort studyObesity

  13. Diabetes Obes Metab

    Finerenone for IgA Nephropathy After Renin‐Angiotensin System Inhibitors Discontinuation: A Multicentre Retrospective Cohort Study

    Cohort study

  14. Diabetes Obes Metab

    Polyendocrine Metabolic Ovarian Syndrome and the Entire Spectrum of Gestational Dysglycemia: A Population‐Based Cohort Study

    Cohort studyDiabetes in pregnancy

  15. Diabetes Obes Metab

    An Observational Study on the Impact of Menstrual Cycle Phases on Carbohydrate Intake, Insulin Delivery and Glycaemia in Women With Type 1 Diabetes Using MiniMed 780G Automated Insulin Delivery System

    Cohort studyTechnology

  16. Diabetes Obes Metab

    Efficacy of Luseogliflozin Added to Semaglutide in Patients With Metabolic Dysfunction‐Associated Steatohepatitis and Type 2 Diabetes Mellitus: A Randomised, Open‐Label Trial

    Randomized controlled trialT2D & other

  17. Diabetes Obes Metab

    Fatty Liver Index and Differential Glycemic Responses to Ipragliflozin Versus Sitagliptin Over 52 Weeks: An Exploratory Post Hoc Analysis of the Niigata Ipragliflozin and Sitagliptin With Metformin (N‐ ISM ) Study

    Secondary analysisT2D & other

  18. Diabetes Obes Metab

    Association of Lipid Ratios With Cardiovascular Outcomes in Type 2 Diabetes: A Population Cohort Study

    Cohort studyT2D & other

  19. Diabetes Obes Metab

    Body Composition Remodelling During GLP ‐1‐Based Therapy: A Systematic Review and Meta‐Analysis Using a Hierarchical Physiological Framework

    Meta-analysisT2D & other

  20. Diabetes Obes Metab

    Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium‐Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes

    Cohort studyT2D & other

  21. Diabetes Obes Metab

    Integrative Proteomics–Metabolomics Profiling of Umbilical Cord Plasma With Machine Learning Reveals Candidate Biomarkers for Gestational Diabetes Mellitus

    Case-control studyDiabetes in pregnancy

  22. Diabetes Obes Metab

    Oleanolic Acid‐Enriched Olive Oil Attenuates Kidney Function Decline in Patients With Type 2 Diabetes: Results From the OLTRAD Randomised Controlled Trial

    Secondary analysisComplications

  23. Diabetes Obes Metab

    Phenotypic Heterogeneity of Diabetic Kidney Disease and Its Association With Cardiovascular and Renal Outcomes: Evidence From a Chinese Multicentre Cohort

    Cohort studyComplications

  24. Diabetes Obes Metab

    Retatrutide‐Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 Diabetes

    Secondary analysisObesity

  25. Diabetes Obes Metab

    Vegetable‐First Meal Sequence Suppresses Postprandial Glycaemic Excursions and Variability in Young Women With High‐Risk Phenotype for Early‐Onset Type 2 Diabetes: A 4‐Arm Randomized Crossover Trial With Continuous Glucose Monitoring

    Randomized controlled trialT2D & other

  26. Diabetes Obes Metab

    When Metabolically Healthy Is Not Low Risk: BMI Thresholds for Incident Diabetes in East Asian Adults

    Cohort studyT2D & other

  27. Diabetes Obes Metab

    Age‐Specific Associations of Moderate‐to‐Vigorous Physical Activity With Relative and Absolute Risk of Type 2 Diabetes in UK Biobank Participants

    Cohort studyT2D & other

  28. Diabetes Obes Metab

    Liraglutide and Βeta‐Cell Function in Young Adults With Long‐Standing Type 1 Diabetes and Residual C‐Peptide: A Blinded, Randomized Controlled Trial

    Randomized controlled trialT1D

  29. Diabetes Obes Metab

    Recurrent Diabetes‐Related Hospital Admissions and Diabetes Distress: Real‐World Evidence From the Association of British Clinical Diabetologists ( ABCD ) National Freestyle Libre Audit

    Cross-sectional studyT1D

  30. Diabetes Obes Metab

    Cardiometabolic Renal Health Profile, Intensive Blood Pressure‐Lowering Treatment and Cognitive Dysfunction: A Post Hoc Analysis of the SPRINT Trial

    Secondary analysis

  31. Diabetes Obes Metab

    Community‐Based Personalised Lifestyle Intervention Guided by Intermittent Continuous Glucose Monitoring in Adults With Type 2 Diabetes: A Multicentre Randomised Controlled Trial

    Randomized controlled trialT2D & other

  32. Diabetes Obes Metab

    Association of GLP ‐1 Receptor Agonist Use With Cardiovascular Outcomes and Mortality in Japanese Patients With Type 2 Diabetes: A Real‐World Claims Database Study

    Cohort studyT2D & other

  33. Diabetes Obes Metab

    Predictive Modelling of 3‐Month Glycemic Target Achievement in Type 2 Diabetes Mellitus Using Artificial Intelligence and Continuous Glucose Monitoring: A Retrospective Cohort Study

    Cohort studyTechnology

  34. Diabetes Obes Metab

    Quality of Diabetes Care Among Older Adults in Germany—Results of the Study on Health of Older People 2022/2023 Compared With Previous National Health Surveys

    Cross-sectional studyT2D & other

  35. Diabetes Obes Metab

    AI Patient Support and 6‐Month Medication Adherence in a Digital Obesity Program: A Retrospective Analysis

    Cohort studyObesity

  36. Diabetes Obes Metab

    Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated and GRADE Assessed Systematic Review and Meta‐Analysis of Randomised Controlled Trials

    Meta-analysisLipids & liver

  37. Diabetes Obes Metab

    Feasibility and Effects of a Produce Prescription Program ( PRx ) in People With Type 2 Diabetes and Low Socioeconomic Status: A Randomised Controlled Pilot Trial

    Randomized controlled trialT2D & other

  38. Diabetes Obes Metab

    Tirzepatide Persistence and Associated Changes in Clinical Outcomes in US Adults With Obesity or Overweight: A 6‐Month Claims Database Analysis

    Cohort studyObesity

  39. Diabetes Obes Metab

    Associations of Adiposity With Cortical Atrophy and Network Dyssynchrony in Type 2 Diabetes: A Multimodal MRI Study

    Cross-sectional study

  40. Diabetes Obes Metab

    Bowel Obstruction/Ileus Associated With the Use of Glucagon‐Like Peptide‐1 Receptor Agonists: A Nationwide Database Study

    Cohort studyT2D & other

All 2,200 Briefs in ExploreShowing Briefs 121–160 of 2,200, newest first